Malignant neuroleptic syndrome treated with bromocriptine
Fernández Ballesteros, A.; Cervero Jiménez, M.; Marco Martínez, J.; Martín Joven, A.
Revista Clinica Espanola 192(1): 49
1993
ISSN/ISBN: 0014-2565 PMID: 8465032 Document Number: 413987
Document emailed within 1 workday
Related Documents
Kunju, P.A.; Bhaskaran, R.; Nair, K.R. 1990: Neuroleptic malignant syndrome improved by bromocriptine Journal of the Association of Physicians of India 38(5): 358-359Azorin, J.M.; Bouchacourt, M.; Lavergne, T.; Giudicelli, S. 1984: Neuroleptic malignant syndrome. Efficacy of bromocriptine Presse Medicale 13(27): 1702
Mueller, P.S.; Vester, J.W.; Fermaglich, J. 1983: Neuroleptic malignant syndrome. Successful treatment with bromocriptine JAMA 249(3): 386-388
McCarron, M.M.; Boettger, M.L.; Peck, J.J. 1982: A case of neuroleptic malignant syndrome successfully treated with amantadine Journal of Clinical Psychiatry 43(9): 381-382
Van Waarde, J.A.; Muller, M.E.T.M.; Verweg, B. 2006: Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively Nederlands Tijdschrift Voor Geneeskunde 150(46): 2517-2520
Lambrecht, E.R.; Meems, B.J. 1987: A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa Netherlands Journal of Medicine 30(1-2): 80-84
Osoegawa, M.; Motomura, S.; Yamanaka, H.; Tamura, K.; Miyoshi, T. 1999: A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation Rinsho Shinkeigaku 39(6): 653-657
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Theau, D.; Missoum, A. 1986: Severe dystonia syndrome successfully treated with bromocriptine and ataxia-telangiectasia syndrome in a single family Archives Francaises de Pediatrie 43(7): 538
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Segado Soriano, A.; López Gonzalez-Cobos, C.; Villalba Garciá, M.V.; Gil Gómez, J.; Muiño Miguez, A.; Millan Núñez-Cortés, J. 1997: Malignant neuroleptic syndrome Anales de Medicina Interna 14(5): 231-235
Müller, T.; Becker, T.; Fritze, J. 1989: Neuroleptic malignant syndrome Deutsche Medizinische Wochenschrift 114(11): 442-443
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Kishida, I.; Furuno, T.; Kawanishi, C. 2012: Neuroleptic malignant syndrome (NMS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 612-615
Kimsey, L.R.; Gibbs, J.T.; Glen, R.S.; Markette, J.R.; Kosted, E. 1983: The neuroleptic malignant syndrome Texas Medicine 79(10): 54-55
Retamal, P. 1990: Neuroleptic malignant syndrome Revista Medica de Chile 118(6): 679-685
Bidzińska, E. 1986: Malignant neuroleptic syndrome Psychiatria Polska 20(6): 483-488
Suchanová, L. 1985: Malignant neuroleptic syndrome Ceskoslovenska Psychiatrie 81(2): 91-95
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Martínez, E.; Domingo, P.; Lloret, J. 1994: Malignant neuroleptic syndrome Medicina Clinica 102(5): 181-188